Korean Medication Algorithm for Bipolar Disorder 2018 : Mixed Features / 우울ㆍ조울병
Mood and Emotion
; (2): 69-76, 2018.
Article
en Ko
| WPRIM
| ID: wpr-786882
Biblioteca responsable:
WPRO
ABSTRACT
OBJECTIVES: The Korean Medication Algorithm for Bipolar Disorder 2018 (KMAP-BP 2018) has been revised again as a result of a consensus of opinions among experts. The mixed episode was changed to mixed features in DSM-5. In this study, we will describe the preference and recommendation of KMAP-BP 2018 for the treatment of mood episodes with mixed features.METHODS: Out of 84 members of the review committee, 61 completed the survey. We analyzed the answers, discussed the data, and held a clinician hearing.RESULTS: The preferred first-step strategies for mixed features with more manic symptoms were a combination of mood stabilizers (MS), atypical antipsychotics (AAP), and AAP monotherapy. For mixed features with more depressive symptoms, a combination of MS and lamotrigine (LTG), a combination of MS and AAP, and a combination of AAP and LTG were preferred. For mixed features with manic and depressive symptoms, a combination of MS and AAP, and AAP monotherapy were preferred.CONCLUSION: For mixed features, a combination of MS and AAP was generally preferred, and lamotrigine was preferred for depressive symptoms. We hope this KMAP-BP 2018 to be helpful for clinicians that treat patients with bipolar disorder in Korea.
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Antipsicóticos
/
Trastorno Bipolar
/
Comités Consultivos
/
Consenso
/
Depresión
/
Esperanza
/
Audición
/
Corea (Geográfico)
Tipo de estudio:
Guideline
/
Prognostic_studies
Límite:
Humans
País/Región como asunto:
Asia
Idioma:
Ko
Revista:
Mood and Emotion
Año:
2018
Tipo del documento:
Article